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Objectives
Patients with atrial ﬁbrillation (AF) have an increased risk of de-
veloping stroke, and oral anticoagulants (OACs) are commonly
used in stroke prevention. The CHA2DS2-VASc score has been
proved to be a simple and eﬀective tool for stroke risk assess-
ment which guides the selection of treatment with OACs. This
score is calculated using disease diagnoses; however, a range of
diﬀerent versions exist, making comparability questionable.
The aim of this study was to compare CHA2DS2-VASc scores
in OAC treated patients with a hospital-conﬁrmed diagnosis of
AF in Scotland using diﬀerent subsets of ICD-10 codes.
Approach
This is a retrospective study, covering AF patients in Scotland
who received at least one prescription for any OAC between Jan-
uary 2009 and June 2014. The Prescribing Information System
(PIS) was used to identify patients with OAC prescriptions, while
the Scottish Morbidity Records (SMR) provided patientsâĂŹ di-
agnoses. Diﬀerent sets of ICD-10 codes, using varying deﬁni-
tions, were used to classify the stroke risk in AF patients in or-
der to account for heterogenous deﬁnitions applied in previously
published studies. The main diﬀerences in codes used were the
inclusion or exclusion of unclassiﬁed stroke (ICD-10 code I64),
and the inclusion of pulmonary embolism (PE) (I26) as either
“prior thromboembolic event” or “vascular disease”.
Results
In our study, a cohort of 71012 AF patients with OAC prescrip-
tion were analysed. Using narrow disease deﬁnitions, 18.15% of
patients were categorised as being at low risk of stroke (score
0-1), 74.80% at medium risk (score 2-5), and 7.04% at high risk
(score 6-9). With an extended disease deﬁnition, including PE
in “prior thromboembolic event”, 14.81% of patients were at low
risk (score 0-1), 72.60% at medium risk (score 2-5), and 12.59%
at high risk (score 6-9); while including PE in “vascular disease”,
14.99% of the patients had a score 0-1, 73.54% a score 2-5, and
11.48% a score 6-9.
Conclusion
The change in score deﬁnitions makes a diﬀerence mainly in
the number of patients categorised as very low risk or high risk.
Standardisation in ICD-10 code deﬁnition of risk diseases could
be useful in order to make the results comparable from diﬀerent
studies and further evaluate OAC choice according to risk group.
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